To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer
NCT ID:
NCT05704231
Condition:
Non-Muscle Invasive Bladder Cancer
Self Efficacy
Smoking Behaviors
Tumor Recurrence
Progression, Disease
Conditions: Official terms:
Urinary Bladder Neoplasms
Non-Muscle Invasive Bladder Neoplasms
Disease Progression
Recurrence
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
This study is a parallel group randomized controlled study.
Primary purpose:
Supportive Care
Masking:
Single (Participant)
Masking description:
Single (Participant)
Intervention:
Intervention type:
Behavioral
Intervention name:
Behavioral: Motivational Interviewing with WhatsApp video call
Description:
The intervention group will be given a motivational interview with a WhatsApp video call
for 3 months. Motivational interviews will be applied every two weeks, 6 times in total.
Arm group label:
Experimental: Intervention Group
Summary:
This study will be carried out to examine the effect of telephone-assisted smoking
cessation program on self-efficacy, smoking behavior, tumor recurrence and progression in
patients with non-muscle invasive bladder cancer.
Detailed description:
This study will be conducted to examine the effect of a telephone-assisted smoking
cessation program (3 months) on self-efficacy, smoking behavior, tumor recurrence and
progression for chronic disease management in patients diagnosed with non-muscle invasive
bladder cancer. After 3 months of motivational interviewing was applied to the
experimental group, the scales will be applied in the 3rd, 6th and 12th months. The
cystoscopy will be performed at 3 and 12 months for tumor recurrence and progression
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Being 21 years or older
- First-time diagnosis of non-muscle invasive bladder cancer (patients with pTa
urothelial cancer)
- Chronic smoking for at least 1 year
- At least primary school graduate and can speak Turkish
- Having a smartphone and internet access
- No communication barrier (speech, vision or hearing problem)
- Individuals who agree to participate in the research.
Exclusion Criteria:
- Patients with positive CIS (carcinoma in situ)
- Patients with minimal invasion of the lamina propria and above
- Patients with extravesical extension
- Patients with synchronous and metachronous tumors
- Communication disability (speech, vision or hearing problem)
Gender:
All
Minimum age:
21 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
İrem Nur Ozdemir
Address:
City:
Istanbul
Country:
Turkey
Start date:
February 1, 2023
Completion date:
June 1, 2024
Lead sponsor:
Agency:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Agency class:
Other
Source:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05704231
